Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide in Recurrent Oligodendroglial Tumors After PCV-Chemotherapy
NCT00003304Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Apr 1998
- Primary completion
- Mar 2000
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of temozolomide in Oligodendroglioma (OG), oligoastrocytoma, sponsored by European Organisation for Research and Treatment of Cancer. Started Apr 1998; status: completed.
02
Drugs
temozolomide
03
Conditions
Oligodendroglioma (OG)oligoastrocytoma
Beyond the preview
Go deeper on NCT00003304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003304.